These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 16377121)

  • 1. [Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation].
    Blanloeil Y; Rigal JC; Bastien O; Carteau JP; Toussaint-Hacquard M; Lecompte T
    Ann Fr Anesth Reanim; 2006 Jan; 25(1):2-5. PubMed ID: 16377121
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients.
    Hardy JF; Bélisle S; Van der Linden P
    Curr Opin Anaesthesiol; 2009 Feb; 22(1):95-9. PubMed ID: 19295298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis.
    Ponschab M; Landoni G; Biondi-Zoccai G; Bignami E; Frati E; Nicolotti D; Monaco F; Pappalardo F; Zangrillo A
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):804-10. PubMed ID: 21596585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in cardiac surgery: a systematic review.
    Warren O; Mandal K; Hadjianastassiou V; Knowlton L; Panesar S; John K; Darzi A; Athanasiou T
    Ann Thorac Surg; 2007 Feb; 83(2):707-14. PubMed ID: 17258029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential thrombogenic complications with the use of recombinant activated factor VII in combat trauma.
    Fareed J; Bick RL; Kessler C; Messmore HL; Rao G; Sasahara A; Haas S
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):121-3. PubMed ID: 17456619
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients.
    Felfernig M; Huepfl M
    Clin Neurol Neurosurg; 2008 Mar; 110(3):227-32. PubMed ID: 18083302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: are they appropriate and safe?
    Aledort LM
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2112-3. PubMed ID: 14688750
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
    Meijer K; Sieders E; Slooff MJ; de Wolf JT; van der Meer J
    Thromb Haemost; 1998 Jul; 80(1):204-5. PubMed ID: 9684815
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
    Branch DW; Rodgers GM
    Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of activated recombinant FVII in the control of haemorrhage following trauma].
    Perrier V; Morel N; Bernard JC; Julliac B; Dewitte A; Pouquet O; Sztark F; Dabadie P
    Ann Fr Anesth Reanim; 2006 Sep; 25(9):990-3. PubMed ID: 16926088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII for non-hemophiliac bleeding patients.
    Uhlmann EJ; Eby CS
    Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
    Levi M
    J Thromb Haemost; 2007 Feb; 5(2):242-3. PubMed ID: 17181827
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro/con debate: does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?
    Pieri P; Stein DM; Scarpelini S; Rizoli S
    Crit Care; 2006; 10(3):214. PubMed ID: 16762042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
    Hünseler C; Kribs A; Eifinger F; Roth B
    J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of recombinant factor VIIa: a rebuttal.
    Teitel J; Poon MC
    J Thromb Haemost; 2004 Nov; 2(11):2078; author reply 2079. PubMed ID: 15550060
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.